Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
04/06/2010 | US7691575 identifying a composition that increase immune response; Asteraceae plant extract; identifying stable compositions for increasing endogenous cytokine levels |
04/06/2010 | US7691569 detecting the expression level of a nucleic acid depending upon the rate of hematopoiesis or the distribution of hematopoietic cells along their maturation pathway in patient |
04/06/2010 | US7691566 Compositions and methods for treatment of cancer |
04/06/2010 | US7691564 detecting G protein coupled receptor signaling in the presence of a test sample using fluorescence resonance energy transfer (FRET); for drug screening and G-protein couple receptors (GPCRs) de-orphaning |
04/06/2010 | US7691414 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
04/06/2010 | US7691395 BASB119 polypeptide and polynucleotide from Moraxella catarrhalis |
04/06/2010 | US7691393 Listeria attenuated for entry into non-phagocytic cells, vaccines comprising the Listeria, and methods of use thereof |
04/06/2010 | US7691390 polypeptide and isolated nucleic acid encoding the polypeptide for SARS CoV protein 3a, which can serve as a target for elucidating the mechanisms of SARS and developing vaccines and therapeutics |
04/06/2010 | US7691385 Polypeptides encoded by polynucleotides that are useful for detecting resistance to streptogramin A or to streptogramin B and related compounds |
04/06/2010 | US7691384 using a human Fc epsilon receptor (Fc68 R) to detect epsilon immunoglobulin (IgE); detecting a plant allergy in a canid, felid or equid |
04/06/2010 | US7691378 Treating carcinomas or adenocarcinomas using at least one anti-TNF (tumor necrosis factor) antibody |
04/06/2010 | US7691376 monoclonal antibodies or fragment thereof which binds a cell surface glycoprotein antigen located on the surface of human multiple myeloma tumor cells; for therapeutic, screening, diagnostic and cell purification purposes |
04/06/2010 | US7691373 Antibody that binds to mammalian Dendritic Cell Membrane Protein (DCMP) genes; immunostimulants |
04/06/2010 | US7691370 Selectivity replicating viral vector |
04/06/2010 | CA2617830C Direct molecular cloning of a modified eukaryotic cytoplasmic dna virus genome |
04/06/2010 | CA2462506C Compositions, methods and kits pertaining to luminescent compounds |
04/06/2010 | CA2445035C Mutants of green fluorescent protein |
04/06/2010 | CA2406807C Methods and compositions for the prevention and treatment of anemia |
04/06/2010 | CA2381954C Method for detecting nucleic acid target sequences involving in vitro transcription from an rna polymerase promoter |
04/06/2010 | CA2380847C Mutant gene of the gras family and plants with reduced development containing said mutant gene |
04/06/2010 | CA2378925C Matrix-targeted fusion polypeptides for tissue regeneration and wound healing |
04/06/2010 | CA2303477C Chimaeric adenoviruses |
04/06/2010 | CA2280930C Protein markers for lung cancer and use thereof |
04/06/2010 | CA2271952C Il-9 receptor variants, useful in treating and diagnosing atopic allergies including asthma and related disorders |
04/06/2010 | CA2253243C Antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
04/06/2010 | CA2252466C Hepatitis b monoclonal antibodies |
04/06/2010 | CA2240390C Novel xylanases, genes encoding them, and uses thereof |
04/06/2010 | CA2235393C Therapeutic antiangiogenic endostatin compositions and methods of use |
04/06/2010 | CA2219090C Universal targets for species identification |
04/06/2010 | CA2193491C Replication-competent herpes simplex virus mediates destruction of neoplastic cells |
04/06/2010 | CA2188919C Monoclonal antibodies which promote central nervous system remyelination |
04/06/2010 | CA2181334C Bacterial strains of genus bacillus closely phenotypically related to genus lactobacillus, culture method and use |
04/06/2010 | CA2161867C Means for detecting familial colon cancer (fcc) |
04/06/2010 | CA1341602C Promotors of filamentous fungi and use thereof |
04/03/2010 | CA2640415A1 Methods for predicting and detecting intolerance to an hypolipidemic agent |
04/01/2010 | WO2010037143A1 Vectors and methods of treating brain seizures |
04/01/2010 | WO2010037124A1 Tumor vascular marker-targeted vaccines |
04/01/2010 | WO2010037111A1 INCREASED HETEROLOGOUS Fe-S ENZYME ACTIIVTY IN YEAST |
04/01/2010 | WO2010037105A1 Enhanced dihydroxy-acid dehydratase activity in lactic acid bacteria |
04/01/2010 | WO2010037061A1 Herbicide-resistant ahas-mutants and methods of use |
04/01/2010 | WO2010037057A1 Herbicide-resistant ahas-mutants and methods of use |
04/01/2010 | WO2010036986A2 Recombinant vectors |
04/01/2010 | WO2010036979A2 Novel vectors for production of interferon |
04/01/2010 | WO2010036978A2 Novel vectors for production of growth hormone |
04/01/2010 | WO2010036976A2 Novel vectors for production of antibodies |
04/01/2010 | WO2010036970A2 Influenza vaccines, antigens, compositions, and methods |
04/01/2010 | WO2010036969A2 Genetic markers for assessing risk of developing schizophrenia |
04/01/2010 | WO2010036965A2 Genetic markers of schizophrenia endophenotypes |
04/01/2010 | WO2010036964A2 Modified animal erythropoietin polypeptides and their uses |
04/01/2010 | WO2010036962A1 Lipid formulated compositions and methods for inhibiting expression of serum amyloid a gene |
04/01/2010 | WO2010036960A2 Methods for treating, diagnosing, and monitoring lupus |
04/01/2010 | WO2010036957A1 Systems and methods for magnetic guidance and patterning of cells and materials |
04/01/2010 | WO2010036946A1 Chimeric plant promoters and their uses in plants |
04/01/2010 | WO2010036943A2 Genetic markers for assessing risk of developing bipolar disorder |
04/01/2010 | WO2010036923A1 Induced pluripotent stem cells and methods of use |
04/01/2010 | WO2010036918A2 Intracellular dna receptor |
04/01/2010 | WO2010036880A2 Selection system for di-iron [fefe] hydrogenase properties |
04/01/2010 | WO2010036866A1 Nitrogen responsive early nodulin gene |
04/01/2010 | WO2010036860A2 Compatible display vector systems |
04/01/2010 | WO2010036856A2 Compatible display vector systems |
04/01/2010 | WO2010036795A2 Screening methods for identifying specific staphylococcus aureus inhibitors |
04/01/2010 | WO2010036771A2 Herbicide-resistant ahas-mutants and methods of use |
04/01/2010 | WO2010036515A1 Alpha-amylase blends and methods for using said blends |
04/01/2010 | WO2010036391A2 A novel rna-based expression system |
04/01/2010 | WO2010036353A2 Genetic markers for optimizing treatment for schizophrenia |
04/01/2010 | WO2010036293A1 Malaria vaccine |
04/01/2010 | WO2010036132A1 Novel bacteriophage strains for the treatment of bacterial infections, especially drug resistant strains of the genus enterococcus |
04/01/2010 | WO2010036118A1 Porphobilinogen deaminase gene therapy |
04/01/2010 | WO2010036111A1 Means and methods for counteracting, preventing and/or determining fibrosis or a risk of fibrosis |
04/01/2010 | WO2010035954A2 Vaccine composition for prevention or treatment of pneumococcal infections comprising vncr/s operon-disabled streptococcus pneumonia mutant strain or pep27 peptide |
04/01/2010 | WO2010035888A1 Biomarker for microdomain disorder |
04/01/2010 | WO2010035837A1 Succinic acid and process for producing same |
04/01/2010 | WO2010035784A1 Gene capable of increasing amount of plant biomass, and method for utilizing same |
04/01/2010 | WO2010035769A1 Improved antibody molecule |
04/01/2010 | WO2010035756A1 Immunoglobulin-binding protein |
04/01/2010 | WO2010035725A1 Aptamer for ngf and use thereof |
04/01/2010 | WO2010035686A1 Method for specifying habitat area of insect |
04/01/2010 | WO2010035618A1 Method for production of plant imparted with stress tolerance and use thereof |
04/01/2010 | WO2010035575A1 Melanin production inhibitor and skin-whitening cosmetic |
04/01/2010 | WO2010035465A1 Anti-tuna vasa antibody |
04/01/2010 | WO2010035304A2 Oligonucleotidic sequences able to silence the expression of the cyclin d1 -trop2 chimera and uses thereof in medical field |
04/01/2010 | WO2010035231A1 Sense and antisense transcripts of trpm2 and uses thereof |
04/01/2010 | WO2010034862A1 Rci5 transgenic plant resistant to cold and saline stress producing tmao, elements necessary for its obtainment, and use of compositions containing tmao to induce tolerance to cold and saline stress |
04/01/2010 | WO2010034845A1 Rodent cancer model for human fgfr4 arg388 polymorphism |
04/01/2010 | WO2010034784A1 Antimicrobial peptides |
04/01/2010 | WO2010034758A2 dsRNA FOR TREATING VIRAL INFECTION |
04/01/2010 | WO2010034752A1 Bioluminescent fungi and their application in the study of fungal infections |
04/01/2010 | WO2010034720A1 Methods for prolonging the health benefits triggered by a dietary restriction using a sphingosine kinase inhibitor |
04/01/2010 | WO2010034708A1 A polynucleotide expression cassette |
04/01/2010 | WO2010034700A1 Treating cancer by modulating rna helicases |
04/01/2010 | WO2010034686A1 Improved statin production |
04/01/2010 | WO2010034681A1 Plants having enhanced yield-related traits and a method for making the same |
04/01/2010 | WO2010034672A1 Plants with increased yield (lt) |
04/01/2010 | WO2010034652A1 Transgenic plants with increased yield |
04/01/2010 | WO2010034590A1 Composition for treating disease |
04/01/2010 | WO2010034487A2 Means for inhibiting the expression of orc-1 |
04/01/2010 | WO2010034314A1 Retroviral delivery of synthectic gene cassettes |
04/01/2010 | WO2010034243A1 Novel gene cluster |
04/01/2010 | WO2010034183A1 Human catechol-o-methyltransferase (comt) assay |
04/01/2010 | WO2010034115A1 Thermostable alcohol dehydrogenase derived from thermococcus guaymasensis |